Stockscreener 앱 받기
373.78
1.00%
2.6894
전일 마감가:
$371.09
열려 있는:
$370.93
하루 거래량:
521.30K
Relative Volume:
0.78
시가총액:
$26.30B
수익:
$3.22B
순이익/손실:
$542.70M
주가수익비율:
49.97
EPS:
7.4805
순현금흐름:
$458.00M
1주 성능:
+3.53%
1개월 성능:
+6.15%
6개월 성능:
+55.26%
1년 성능:
+49.44%
1일 변동 폭
$368.20
$375.42
1주일 범위
$359.52
$375.42
52주 변동 폭
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, RMD, ALC, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
373.71 | 26.12B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
396.85 | 142.05B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
181.79 | 49.85B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
220.52 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
65.17 | 31.71B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.05 | 30.21B | 29.14B | 1.07B | 1.05B | 1.1956 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical stock rises 2.71 percent after analyst upgrade - AD HOC NEWS
West Pharmaceutical stock gains 2.57 percent before the bell - AD HOC NEWS
West Pharmaceutical stock gains as Morgan Stanley turns bullish - AD HOC NEWS
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says - marketscreener.com
West Pharmaceutical Services stock holds near its yearly range - AD HOC NEWS
Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 - Yahoo Finance
West Pharmaceutical stock holds near 52-week high as valuation debate intensifies - AD HOC NEWS
Reasons to Hold Hinge Health Stock in Your Portfolio for Now - Zacks Investment Research
West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Powerhouse with 11.89% Potential Upside - DirectorsTalk Interviews
West Pharmaceutical stock heads into the open after a 1.3% drop - AD HOC NEWS
West Pharmaceutical Services stock holds near fair value as valuation debate intensifies - AD HOC NEWS
What Is Drawing Attention To West Pharmaceutical Services (WST)? - Yahoo Finance
West Pharmaceutical Services stock holds a Moderate Buy rating - AD HOC NEWS
West Pharmaceutical stock holds Moderate Buy rating as Annex 1 work shapes outlook - AD HOC NEWS
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - marketwatch.com
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - yourwyominglink.com
West Pharma to cut 98 jobs as SmartDose production winds down in Arizona - Plastics News
West Pharmaceutical stock slips after recent Fed-driven drop but Q2 2026 results stay strong - AD HOC NEWS
West Pharmaceutical stock heads into the open after a sharp drop - AD HOC NEWS
West Pharmaceutical stock gains after raised 2026 guidance and strong Q2 figures - AD HOC NEWS
West Pharmaceutical stock heads into the open after a 2.76% gain - AD HOC NEWS
Is West Pharmaceutical Services Stock Outperforming the Nasdaq? - inkl
West Pharmaceutical (NYSE: WST) HR leader exercises options, then sells 7,524 shares - Stock Titan
West Pharmaceutical Services Inc (WST): GF Score of 95 Signals S - GuruFocus
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $365 - Moomoo
West Pharmaceutical stock heads into the open after a 1.8% gain - AD HOC NEWS
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - marketwatch.com
West Pharmaceutical Services (WST) Stock Analysis: Robust Growth and a Promising 17% Upside - DirectorsTalk Interviews
West Pharmaceutical stock gains after insider sale and strong Q2 figures - ad-hoc-news.de
West Pharmaceutical Services senior VP favorite sells $2.77m in stock - Investing.com
West Pharmaceutical stock heads into the open after a 0.7 percent dip - ad-hoc-news.de
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M - TradingView
West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan - Stock Titan
West Pharmaceutical CEO Michel Lagarde Granted Stock Options and RSUs in September 2026 - Kalkine Media
WEST PHARMACEUTICAL SERVICES, INC. : UBS RAISES TARGET PRICE TO $415 FROM $340 - webull.com
West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031 - Stock Titan
West Pharmaceutical (NYSE: WST) CEO discloses initial 7,850-share stake - Stock Titan
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts By Investing.com - Investing.com Nigeria
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts - investing.com
West Pharmaceutical stock gains as UBS lifts price target to USD 415 - ad-hoc-news.de
Is West Pharmaceutical Services (WST) Stock A Bargain Or Fully Priced? - webull.com
West Pharmaceutical stock heads before the bell after a 0.8 percent drop - ad-hoc-news.de
West Pharmaceutical (NYSE:WST): Has the Growth Story Been Priced In? - Kalkine Media
West Pharmaceutical stock gains after strong Q2 figures - ad-hoc-news.de
Novocure Reports Patient Data Exposure in Cybersecurity Incident - TradingView
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? - Yahoo Finance
West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector - DirectorsTalk Interviews
Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - indexbox.io
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap - Yahoo Finance
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services stock holds steady as investors eye recent rating and earnings momentum - AD HOC NEWS
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
West Pharmaceutical Services Inc 주식 (WST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 11 '26 |
Option Exercise |
89.64 |
2,500 |
224,100 |
24,318 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 14 '26 |
Option Exercise |
89.64 |
2,500 |
224,100 |
24,318 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 15 '26 |
Sale |
365.00 |
2,524 |
921,260 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 14 '26 |
Sale |
355.00 |
2,500 |
887,500 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 11 '26 |
Sale |
345.00 |
2,500 |
862,500 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 08 '26 |
Option Exercise |
85.37 |
8,135 |
694,453 |
19,663 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 08 '26 |
Sale |
340.81 |
8,135 |
2,772,489 |
16,845 |
1.13%
자본화:
|
볼륨(24시간):